BACKGROUND: Different methods are used by cord blood banks to prepare samples for sterility testing. Suboptimal methods can result in the release of contaminated products. In our organization, samples are prepared by diluting the final product in RPMI-1640 medium. In this work, we have compared our method with different approaches to verify whether optimization should be sought.
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BACKGROUND: Different methods are used by cord blood banks to prepare samples for sterility testing. Suboptimal methods can result in the release of contaminated products. In our organization, samples are prepared by diluting the final product in RPMI-1640 medium. In this work, we have compared our method with different approaches to verify whether optimization should be sought.
STUDY DESIGN AND METHODS:
Cord blood units (n 5 6 units per bacterial strain) characterized to contain inhibitory substances or not were inoculated (10 colonyforming units/mL) with Streptococcus agalactiae, Staphylococcus epidermidis, Klebsiella pneumoniae, Escherichia coli, or Bacteroides fragilis. After plasma and red blood cell removal, stem cell concentrates were diluted in RPMI-1640, thioglycollate, or the unit's plasma. These products, as well as final product, plasma, and red blood cell fractions, were held from 0 to 72 hours at 20 to 248C before inoculation in culture bottles and detection using the BacT/ALERT 3D system.
RESULTS: Dilution of cell concentrates in RPMI-1640
allowed bacterial detection in 93.3% of noninhibitory cord blood samples after a 24-hour storage period. Thioglycollate medium better promoted bacterial growth in inhibitory cord blood samples that were held for 72 hours before testing (66.7%) compared with RPMI-1640 (45.0%). Less than 33% of all spiked plasma samples were detected by the BacT/ALERT 3D system.
CONCLUSION:
Diluting cord blood samples in culture medium containing bacterial growth promoting substances is a suitable option for sterility testing, whereas the use of plasma should be proscribed, because it might lead to false-negative results. Because inhibitory substances affect bacterial growth, inoculation of culture bottles should be done rapidly after sample preparation. U mbilical cord blood (CB) transplantation is indicated for severely immunocompromised patients. These patients have a high risk of contracting infections associated with the transplant. Given the nonsterile collection environment and the numerous procedures carried out before transplantation, microbial contamination of cord blood units (CBUs) is more frequent than for any other blood product. [1] [2] [3] Consequently, the efficient microbial screening of CB donations remains a primary safety concern for cord blood banks (CBBs) while also being required by international accreditation organizations, such as the American Association of Blood Banks and the Foundation for the Accreditation of Cellular Therapy. 4, 5 The development of standardized procedures for microbial screening of CBUs is still being awaited. The lack of consensus standards led to CBBs developing their own method for microbial screening. Generally, a sample of the final volume-reduced CB product is used for sterility testing; however, postprocessing plasma, red blood cell (RBC) fraction, a mixture of these by-products, or a small volume of the final stem cell concentrate (which includes the cryopreservation solution) are also used for microbial screening. [6] [7] [8] [9] [10] Moreover, inoculum volumes, culture bottles being used, as well as delays between CB processing, culture bottle inoculation, and culture launch vary substantially between CBBs. These operational discrepancies likely contribute to the wide variation, ranging from 0 to 48%, in the incidence of contaminated CB products among CBBs. 2, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] In our organization, samples for sterility testing are prepared by diluting from 2 to 4 mL of the final CBU product in 25 mL RPMI-1640 culture medium. Aerobic FA and anaerobic FN bottles (bioM erieux Canada Inc.) are inoculated with 5 to 10 mL each and are incubated for up to 7 days. It has been reported that CB plasma from in-term neonates contains antimicrobial proteins and peptides 20 as well as residual antibiotics resulting from prophylactic treatment of women during labor. [21] [22] [23] The potential influence of antimicrobials in samples used for CB microbial testing has been observed. 7, 24 These substances might influence sterility testing, because they affect the survival of contaminating bacteria in tested samples, leading to false-negative results.
In this work, we challenged and compared our method with different approaches for the preparation of CB samples classified as either inhibitory (iCB) or not (niCB) and performed sterility testing using the automatized BacT/ALERT 3D system. Using five bacteria frequently identified in contaminated CBUs, 2,9,14,18 we compared the use of either RPMI-1640 cell culture medium, thioglycollate bacterial culture medium, or plasma for the dilution of the final product (FP). We also analyzed the suitability of CB plasma, FP, and RBC fraction as samples for sterility testing. Because certain CBBs use an external microbiology laboratory for testing, delays before inoculation of culture bottles were also assessed. Finally, we examined the survival of bacteria in post-thaw CBUs. The ultimate goal of this study was to determine whether changes to our method were needed and, if necessary, to optimize our approach.
MATERIALS AND METHODS

CB collection
The H ema-Qu ebec CBB complies with Canadian Safety Regulations for Human Cells, Tissues, and Organs for Transplantation and is a Foundation for the Accreditation of Cellular Therapy-accredited organization. Informed consent was obtained from donating mothers, in accordance with our approved institutional review board protocol. CB samples (n 5 120) were collected in utero at the hospital sites in closed collection sets containing 35 mL citratephosphate-dextrose (Fenwal, Inc.). The CBUs used in this work were not acceptable for banking because of low volume or number of cells and were 4 days old or less when received in the Research and Development laboratory.
CBUs were kept at 20 to 248C until they were processed.
Bacterial species
Five bacterial species known to be associated with contamination of CBUs were used in this study. 
Disk diffusion assays
The presence of antimicrobial characteristics in CB plasma was assessed using the disk diffusion assay, as described by Cayer as well as others. 24, 26, 27 For the present work, 60 iCB samples and 60 niCB samples were used. In parallel, because of a shortage of iCB samples, 14 niCB samples were inoculated with penicillin G (Sigma Aldrich) to a final concentration of 2.8 mg/mL, which corresponds to the median antibiotic concentration found in plasma from neonates born from a mother who received penicillin during labor. 24 
CB processing and spiking
Two CBUs with the same inhibitory character (iCB or niCB) were pooled before processing to ensure that enough sample volume could be recovered to perform all analyses. Thirty pools of iCB samples and 30 pools of niCB samples were used. A 12-mL sample was removed from each pool for initial sterility testing; 5-mL aliquots from these pools were used to inoculate aerobic FA and anaerobic FN BacT/ALERT 3D system culture bottles (bio-M erieux Canada, Inc.), which were incubated in the BacT/ ALERT automated system for up to 7 days. Bacterial cultures were diluted in citrate-phosphate-dextrose and added to pooled CBUs to a final concentration of 10 CFU/ mL. Spiked CB samples (1 mL) were also plated on blood agar and incubated in aerobic or anaerobic conditions overnight at 378C in duplicate to confirm titers. The use of a 10 CFU/mL inoculum is based on a study by Akel and colleagues, who used concentrations between 10 and 100 CFU/mL for their validation plan of the BACTEC microbial testing method. 7 After spiking, pooled CB samples were volume-reduced to a target volume of 20 6 1 mL by first centrifuging at 3566 3 g for 12 minutes, followed by extraction of plasma and RBC by-products using an Optipress II system (Baxter). After volume reduction and pooling, plasma, RBC, and CB concentrate fractions were weighed. A cryopreservation solution containing 55% dimethyl sulfoxide and 5% Dextran-40 (Alanza, Inc.) was added to the CB concentrate to reach a final concentration of 10% dimethyl sulfoxide and 1% Dextran. This corresponds to the FP, which is normally cryopreserved and banked, while RBC and plasma fractions are discarded. The survival of microorganisms during cryopreservation was verified by freezing six 1-mL FP samples from each spiked CB pool at 2808C for up to 2 hours before it was transferred to liquid nitrogen. Microbial contamination in these samples (1 mL) was determined using the BacT/ ALERT 3D system.
Component preparation for bacterial testing
The overall experimental design is presented in Fig. 1 . Forty-milliliter volumes of RPMI-1640 medium (SigmaAldrich), thioglycollate medium (bioM erieux Canada, Inc.), or plasma isolated from each CB pool were added to three 150-mL collection bags. A volume of 6.4 mL of the diluted FP was added to each of these bags, which represents the actual proportions used in our organization. In addition, aliquots of undiluted FP (0.5 mL and 1 mL), RBCs (1 mL), and plasma (1 mL) from pooled CBUs were tested for microbial contamination. Hence, for each pooled CBU, seven samples were prepared for sterility testing, as described in Table 1 . Samples were tested using the BacT/ALERT 3D automated system after storage of CB products for 0, 24, and 72 hours at ambient temperature (range, 20-248C). Each of the five test microorganisms was spiked in six iCB and six niCB pools, so that each experimental result is derived from six independent experiments (n 5 6).
Statistical analysis
All statistical analyses were done with SAS Enterprise Guide version 4.1 (SAS Institute, Inc.). The omnibus procedure GENMOD was used to analyze the effect of the different approaches to prepare CB components for sterility testing on the detection of bacteria. Differences are considered significant at p < 0.05.
RESULTS
Sensitivity and time before detection of Grampositive and Gram-negative bacteria spiked into CBUs
Bacterial growth was not detected by the BacT/ALERT 3D system in any of the CBUs before spiking, confirming the initial sterility of the 120 CBUs included in this study. Both iCB and niCB pools were spiked with one of two Grampositive or one of three Gram-negative bacterial strains. The percentages of positive units detected by the automated system after inoculation with Gram-positive and Gram-negative bacteria are shown in Figs. 2 and 3, respectively, and incubation times before detection by the BacT/ ALERT 3D system are shown in Table 2 .
Inhibitory substances affect bacterial detection in CB samples
The ability of CBUs to inhibit microbial growth was systematically evaluated by disk diffusion assays. This led to a binary classification of CBUs as either inhibitory (iCB) or noninhibitory (niCB). Table 3 presents results from bacterial concentrations detected in iCB and niCB that had been spiked with the five test microorganisms. Concentrations varied from 12 6 8 CFU/mL to 2 6 2 CFU/mL in niCB; whereas no CFUs were detected in iCB spiked with S. agalactiae, S. epidermidis, or B. fragilis. Concentrations of 5 6 5 CFU/mL and 3 6 2 CFU/mL were detected in iCB spiked with K. pneumoniae and E. coli, respectively. These results indicate that microbial growth-inhibiting characteristics observed in CB alter the survival of spiked bacteria. As presented in Figs. 2 and 3, the percentages detected in spiked niCB were significantly different from those obtained in iCB, regardless of the CB by-product used or the inoculated organism (p 0.0141) (Figs. 2 and 3). Irrespective of the spiked organism, dilution of FP in RPMI-1640 allowed bacterial detection in 93.3% of niCB samples after a 24-hour or 72-hour storage period ( Table 4 ). The use of thioglycollate to dilute FP allowed bacterial detection in 93.3% and 95.0% of niCB samples after a 24-hour or 72-hour storage period, respectively; this represents the highest detection rate observed in the current study (Table  4) . Bacterial detection in iCB samples dropped to 60.0% and 45.0% in cell concentrates diluted in RPMI-1640 after a 24-hour or 72-hour storage period, respectively. Thioglycollate medium appeared to promote greater bacterial survival and growth in iCB samples stored up to 72 hours before testing, because bacterial growth was detected in 78.3% and 66.7% of spiked units after a 24-hour or 72-hour storage period, respectively (Table 4) . Similar results were obtained when plasma, RBCs, or FP were used as samples for sterility testing. However, differences in the percentage of units that exhibited positive growth, ranging from 10% to 62%, were observed between niCB and iCB samples, with lower percentages systematically detected in iCB compared with niCB ( Table 4 ). As shown in Table 2 , incubation times before detection were generally longer for iCB pools.
Plasma isolated from CB inhibits microbial detection
The percentages of microbial detection in CB samples containing plasma were substantially lower than in FP diluted in RPMI-1640, particularly when plasma was directly used as inoculum for microbial detection (B. fragilis, p 5 0.0011; E. coli, p 5 0.002; K. pneumoniae, p < 0.0001; S. agalactiae, p < 0.0001) (Figs. 2 and 3 ). Bacterial contamination was undetectable in plasma prepared from CB inoculated with S. epidermidis and B. fragilis, regardless of whether or not the pool was inhibitory. The percentage detection of S. agalactiae in CB plasma never exceeded 17%; and, at best, two of 12 CB pools were positive for contamination with this bacterium. Likewise, contamination was detected in only two of 12 inhibitory plasma samples inoculated with E. coli. Plasma isolated from niCB (before spiking) was more conducive to microbial detection when used to dilute FP, because more than 75% of inoculated bacteria were detected, except for E. coli, which was detected in 58 to 75% of inoculated niCB samples, depending on storage time before microbial detection testing (Fig. 3B) . When plasma isolated from iCB was used to dilute FP and was spiked with the test bacteria, less than 50% of contaminated samples were detected, excepted for K. pneumoniae, which was detected in 58 to 100% of inoculated samples, depending on storage time before microbial detection testing (Fig. 3A) .
Effect of sampling time on the sensitivity of microbial detection
Higher percentages of microbial detection were observed when sampling for inoculation of culture bottles was performed within the first 24 hours after spiking CB pools with bacteria. Irrespective of the sample tested for microbial detection, the percentages of B. fragilis, S. agalactiae, and S. epidermidis detected were significantly higher or equal when sterility testing was performed after a maximal storage period of 24 hours at room temperature (p 0.015 relative to the 72-hr storage period) (Figs. 2 and  3 ). This observation was particularly true when iCB was used for sample preparation (Table 4) . Regarding the effect of sampling time, no significant differences were observed when E. coli and K. pneumoniae were used as test contaminants (Fig. 3) . were observed when comparing data from CB residual diluted in RPMI-1640 with data from CB diluted in thioglycollate (p 5 0.035). †A significant difference was observed when comparing data from 1 mL FP with data from 0.5 mL FP (p < 0.0001). ‡Significant differences were observed when comparing data from the 0-hour storage condition with data from the 24-hour and 72-hour conditions, irrespective of the CB sample used (p 0.015). §Results obtained with niCB always differed significantly from those obtained with iCB, irrespective of the CB sample used (p < 0.0001).
RBCs and undiluted FP are not the ideal test materials for microbial detection
In general, the percentages of positive units obtained when directly sampling RBCs or FP for microbial detection were comparable to or lower than those obtained with FP diluted in RPMI-1640 culture medium. One noticeable exception concerns the detection of S. agalactiae ( Fig. 2A) . Detection percentages of 92.0% and 75.0% for iCB samples were obtained after storage periods of 24 and 72 hours, respectively, when 1 mL FP was used as the sample for microbial detection, compared with 50.0% or less when RPMI-1640-diluted FP was used after a holding time of 24 hours (p 0.031). Except for E. coli, for which no significant differences were observed, the use of 1.0 mL FP yielded higher percentage detection rates than the use of 0.5 mL FP (p < 0.0001).
Bacterial survival after cryopreservation
The results presented in Fig. 4 indicate that all CB pools spiked with S. agalactiae and K. pneumoniae were detected by the BacT/ALERT 3D system. In total, 92% of niCBUs contaminated with S. epidermidis and B. fragilis were detected, whereas growth of E. coli was detected in 67% of contaminated FP units from niCBUs. Only 17%, 42%, and 67% of iCB FP samples contaminated with S. epidermidis, E. coli, and B. fragilis were detected, respectively. Overall, the trends were very similar to those observed for 1-mL FP samples tested immediately after preparation (t 5 0) (Figs. 2 and 3) and further suggest that the bacteria used in this study are highly resistant to cryopreservation.
DISCUSSION
Approaches for microbial detection of CBUs intended for transplantation vary widely among CBBs. Various factors, such as CB sample type and the presence of inhibitory substances in a sample, can affect bacterial detection. 28 In this work, we have compared some of these factors in order to determine the optimal conditions for CB microbial screening. The use of culture media like RPMI-1640 and thioglycollate to dilute FP appears to be the most advantageous method to prepare CB samples for sterility testing. Thioglycollate medium, which is typically used for bacterial culture, seems to favor the survival of microorganisms even when inhibitors are present in the sample. RPMI-1640, a medium typically used for mammalian cell culture, is also efficient at maintaining bacterial viability and sensitivity in the context of microbial detection screening. In contrast, plasma and direct inoculation of FP and by-products (RBCs and plasma) were less suitable for sampling and microbial detection in CBUs.
Bacterial growth inhibitors present in CB might be associated with antimicrobial peptides and proteins, such as antibody or complement, present in CB plasma. In North America, antibiotic prophylaxis used in 10 to 35% of pregnant women to prevent Group B streptococci infections during obstetric procedures could also contribute to the bacterial-inhibiting potency of CB. 21, 23 29 The present work also underlines the fact that the volume of plasma in the inoculum used for microbial detection should be minimized to ensure the survival of potential contaminating bacteria and to reduce the risk of false-negative results. Riedel and colleagues have observed that bacterial contamination in spiked CB samples is more readily detected by automated systems when whole blood units or RBCs, rather than CB plasma, are used as inoculum. 30 In addition, Clark and coworkers have demonstrated that screening CB for microbial contamination using the plasma fraction yielded a detection rate of 27%, which is consistent with our results; whereas inocula made with a mixture of plasma, RBCs, and FP led to a detection rate that reached 71%. 28 Our current operational procedure, which requests an approximate five times dilution of the FP in RPMI-1640 culture medium, likely contributes to reducing the concentration of inhibitory substances and consequently attenuating their impact on microbial survival. These findings highlight the importance of considering the possible presence of antimicrobial substances in CB when validating a sampling method for microbial detection testing. Penicillin is the first antibiotic used to prevent Group B streptococci infections during obstetric procedures in North America. 21, 23 In this work, we use bacterial agents with different penicillin-susceptibility patterns. K. pneumoniae carries a resistance gene that naturally prevents the action of penicillins. 31 Resistance to penicillin in E. coli readily develops by acquisition of mobile genetic elements. 31 Ma and colleagues have demonstrated that S. epidermidis could have a high resistance profile to antibiotics, including penicillin. 32 In contrast, studies have indicated that B. fragilis and S. agalactiae are very susceptible to penicillin. 33, 34 Except for K. pneumoniae, our results demonstrate a higher percentage of microbial detection in niCB compared with iCB, illustrating a bacterial susceptibility to inhibitory substances (Figs. 2 and 3 ). Samples inoculated with K. pneumoniae exhibit a similar detection rate between niCB and iCB excepted when plasma samples or RBCs are used as matrices for detection tests. For each of these bacterial species, we have to note that susceptibility to penicillin can differ among strains. Our results suggest that the rates of microbial detection in iCB are generally higher when samples are rapidly inoculated (within 24 hr from sampling) into culture bottles. Time of contact between contaminating bacteria and inhibitory substances in CB can reduce microbial growth and survival, 29 underlining the necessity to reduce as much as possible the time interval between CB sampling and inoculation of culture bottles. However, when plasma isolated from CB contaminated with Gram-negative bacteria is used as direct inoculum, it appears that a 24-hour to 72-hour hold period before inoculation of culture bottles is beneficial to microbial detection (Fig. 3) . A short period of a few hours at room temperature appears to favor bacterial growth in culture bottles. Effectively, Akel and coworkers also observed that vials of bacteria incubated at room temperature for 6 to 8 hours before inoculation of culture bottles led to more rapid growth adaptation than bacteria seeded without prior incubation at room temperature. 7 In addition, the current results demonstrate that, except for two assays, there is no advantage in using RBCs or FP as test samples for microbial detection, irrespective of the sample volume used, over the method currently used in our organization. Given that FP corresponds to the product to be administered to the patient, it should be the most appropriate sample for sterility monitoring. However, the limited sample volume of FP available for sterility testing prompted CBBs to develop alternative approaches to test CBUs. The small volume of FP samples (0.5 or 1.0 mL) generally used by CBBs might not be sufficient to ensure optimal microbial detection, whereas the use of higher inoculum volumes of stem cell concentrate increases the sensitivity of detection, especially when contamination levels are low. 2 Many CBBs have tried to optimize microbial detection in CB by using plasma only or mixtures of CB by-products. 1, 6, 7, 9, 28, 29 These methods yielded detection rates ranging from 21% to 79%. Lower detection rates were obtained when plasma only was used. 7 These results are similar to ours regarding detection rates, which, using either iCB or niCB, vary from 6.7% (plasma only) to 95.0% (thioglycollate 1 FP), depending on the tested sample and the delay before the inoculation of culture bottles (Table 4 ). The use of culture media containing bacterial growth substances to dilute the FP increases the percentage detection compared with the use of RBC fractions or FP alone. The contribution of these media to the enhancement of bacterial survival and growth is a likely explanation for the higher detection rates observed with RPMI-1640 and thioglycollate. The use of diluted FP, which, despite dilution, is identical to the original CB donation collected, should be representative of the actual bacterial content of the FP to be administered to the patient. Khuu and colleagues observed that P. acnes, a bacterium of the normal skin flora and often found in blood products, especially platelets, 35, 36 completely failed to grow and could not be detected by the BacT/ALERT system; however, it was detected by the BACTEC system. 15 We observed very similar results when this bacterium could not be detected in any of the conditions tested in the current study (data not shown). It appears either that the sensitivity of the detection method is defective or that P. acnes is rapidly inactivated by antimicrobial CB substances. Khuu and coworkers suggested that perhaps some substances, such as charcoal present in BacT/ ALERT bottles, could inhibit the growth of this bacterium. Others demonstrated that the use of bottles with antibiotic-neutralizing ingredients allow growth of microorganisms in CB that would not occur with conventional media such as P. acnes. 7, 37, 38 Recently, Akel and colleagues described a clever validation approach fulfilling regulatory requirements regarding CB sterility using BACTEC Plus medium. This medium contains resin-neutralizing antibiotics, which were present in as much as 30% of their CB units. 7 By following the strategy outlined in their report, Akel and coworkers were able to detect all organisms spiked in CB by-products (plasma and RBC), including P. acnes.
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In a study published in 2012, Mastronardi and colleagues shed light on the challenge of detecting anaerobic organisms compared with aerobes. 6 In the present study, B. fragilis was the only anaerobe organism studied. We observed some discrepancies between the number of samples spiked with B. fragilis that were detected using FA and FN bottles; however, this discrepancy was only observed in iCB pools (data not shown). Similar observations were made with S. agalactiae and S. epidermidis. Notwithstanding these exceptions, identical detection rates were obtained with FA and FN bottles for all microorganisms tested in niCB. Recent studies reported that aerobic and anaerobic organisms are preferentially sequestered in different CB 28, [35] [36] [37] 39 fractions, supporting the idea of using mixtures of CB by-products when testing for microbial contamination in CB. These findings underline the importance for CBBs to develop a screening method that uses both aerobe and anaerobe culture bottles. The BacT/ALERT 3D system detected bacterial growth in all FP samples that were subjected to a freezethaw cycle after spiking with S. agalactiae and K. pneumoniae and the majority of niCB samples spiked with S. epidermidis, E. coli, and B. fragilis before cryopreservation. Similar results were obtained by Honohan and coworkers, who detected 24 contaminated samples out of 25 after thawing. 2 In a study by Clark and colleagues, a post-thawing detection rate of 85% was obtained in spiked CB. 40 These findings indicate that the bacteria used in the current study are highly resistant to cryopreservation. This observation bears particular relevance for those CBBs that use thawed FP to test for microbial contamination. The results from this study suggest that: 1) plasma, alone or combined with other CB fractions, is not suitable for bacterial detection; 2) in a CB facility where the inoculation of bottles is done within a certain delay, dilution of FP in a culture medium appears to maximize detection of microbial contamination; 3) culture bottles containing antibiotic-neutralizing adsorbents should be used; 4) inoculation of culture bottles must be done within 24 hours after CB sample preparation; and 5) use of bottles that are permissive for detection of both aerobe and anaerobe organisms should be followed. These measures should help CBBs to improve microbial detection, ultimately leading to the release of safer products. Upon completion of this study, changes have been implemented in our in-house strategy for sterility testing of CB samples, including a reduction in the delay before inoculation of culture bottles and the implementation of FA Plus and FN Plus culture bottles (bioM erieux) to increase antimicrobial neutralization. Defining the optimal CB inoculum and how it should be prepared and stored before the inoculation are crucial parameters to ensure reliable results and safer products intended for infusion to patients.
